Lv1
30 积分 2025-07-16 加入
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
22天前
已完结
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification
22天前
已完结
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer
22天前
已完结
A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment
22天前
已完结
An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma
1个月前
已完结
Interstitial lung disease biomarkers: a systematic review and meta-analysis
2个月前
已完结
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
2个月前
已完结
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
3个月前
已完结
EGFR as a Potential Target for the Treatment of Pancreatic Cancer: Dilemma and Controversies
4个月前
已完结
Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
4个月前
已完结
皖公网安备34019202002308
